[1] |
Shan′gao HUANG,Yueling WU,Ying. ZHANG.
Aiming for the future: The latest advances in targeted therapy for ovarian cancer
[J]. The Journal of Practical Medicine, 2024, 40(14): 1901-1907.
|
[2] |
Ping YIN,Hanzi XU,Chenjing. ZHU.
Application of ctDNA in gynecological malignant cancer
[J]. The Journal of Practical Medicine, 2023, 39(17): 2153-2158.
|
[3] |
Lin LIU,Runrong LI,Shipeng. GONG.
Efficacy and safety of PEG⁃rhG⁃CSF for preventing neutropenia after chemotherapy with doxorubicin plus carboplatin in epithelial ovarian cancer patients: A retrospective clinical study
[J]. The Journal of Practical Medicine, 2023, 39(17): 2236-2240.
|
[4] |
Chongfeng SUN,Ping YANG,Jishuai HOU,Zouyu ZHAO,Panpan. YU.
Expression and prognosis of STT3A and STT3B in epithelial ovarian cancer
[J]. The Journal of Practical Medicine, 2023, 39(16): 2062-2070.
|
[5] |
Jianxiang CHENG,Wensheng DU,Min WEI,Guanghui. WANG.
Expression of LMNB1 in ovarian cancer and its effect on biological behavior of ovarian cancer cells
[J]. The Journal of Practical Medicine, 2023, 39(16): 2077-2084.
|
[6] |
PENG Jiaxin, ZHANG Zihui, HONG Li. .
Role of m6A modification in ovarian cancer:A review of literature
[J]. The Journal of Practical Medicine, 2023, 39(12): 1577-1583.
|
[7] |
JIANG Ping, GUO Zhe, LIANG Dianxun, YANG Xike, FU Xiaoling, LI Heli.
Influence of long non ⁃coding RNA XIST on epithelial ⁃mesenchymal transition in ovarian cancer cells by regulating miR⁃340⁃5p
[J]. The Journal of Practical Medicine, 2023, 39(1): 41-47.
|
[8] |
PU Yukang, HUANG Yuqin, LI Wei, LI Mingqun..
Expression and clinical significance of KIF26B in epithelial ovarian cancer based on biological information
[J]. The Journal of Practical Medicine, 2022, 38(23): 2919-2926.
|
[9] |
WU Xinhua, GU Xiaoli, HU bin..
MiR ⁃216a inhibits metastasis and epithelial ⁃mesenchymal transition of ovarian cancer cells by regulating the JAK2/STAT3 pathway
[J]. The Journal of Practical Medicine, 2022, 38(18): 2303-2308.
|
[10] |
LI Jianqi, SHENG Xiujie..
The study of the expression of long non⁃coding RNA LINC00467 in ovarian cancer and its clinical signifi⁃ cance
[J]. The Journal of Practical Medicine, 2022, 38(12): 1486-1493.
|
[11] |
LI Xin, ZHANG Yu, NI Tingting, LU Liang..
D1Effect and mechanism of UBE2T gene interference on proliferation of human ovarian cancer cell line SKOV3
[J]. The Journal of Practical Medicine, 2022, 38(10): 1198-1207.
|
[12] |
TONG Luyao, LEI Liyi, CHEN Jun, HUANG Weiling, ZHANG Mei. .
Metabolic syndrome and its components and the risk of ovarian cancer in women:A single center prospec⁃ tive cohort study
[J]. The Journal of Practical Medicine, 2022, 38(10): 1280-1285.
|
[13] |
BAI Xiaozhi, XIE Xiaojuan, YUAN Xiang, LIU Yiwen, KONG Jinyu, SUN Wei, LI Yanle..
Inhibitive effect of propofol on proliferation,migration and invasion of ovarian cancer SKOV3 cells in vitro by down⁃regulating expression of yes⁃associated protein
[J]. The Journal of Practical Medicine, 2021, 37(5): 596-600.
|
[14] |
WANG Tao, SONG Feixue..
Immunotherapy for platinum resistant ovarian cance:A literature review
[J]. The Journal of Practical Medicine, 2021, 37(20): 2575-2579.
|
[15] |
WANG Baojin, XU Lida, ZHAO Xinxin, LIN Shaochong, LI Xia, DU Junpeng, WANG Kai..
KLF4 inhibits the proliferation,invasion and metastasis of ovarian cancer cells by regulating TGF⁃β path⁃ way to weaken EMT
[J]. The Journal of Practical Medicine, 2021, 37(19): 2442-2446.
|